Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs)
R Roskoski Jr - Pharmacological Research, 2021 - Elsevier
Because dysregulation of protein kinases owing to mutations or overexpression plays
causal roles in human diseases, this family of enzymes has become one of the most …
causal roles in human diseases, this family of enzymes has become one of the most …
Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs)
R Roskoski Jr - Pharmacological research, 2021 - pubmed.ncbi.nlm.nih.gov
Because dysregulation of protein kinases owing to mutations or overexpression plays
causal roles in human diseases, this family of enzymes has become one of the most …
causal roles in human diseases, this family of enzymes has become one of the most …
Orally effective FDA-approved protein kinase targeted covalent inhibitors (TCIs).
R Roskoski Jr - Pharmacological Research, 2021 - europepmc.org
Because dysregulation of protein kinases owing to mutations or overexpression plays
causal roles in human diseases, this family of enzymes has become one of the most …
causal roles in human diseases, this family of enzymes has become one of the most …